Featured Articles

Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

By August 17, 2020August 19th, 2024No Comments

Featured Article

Featured Article

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, and external stimuli. Because PIH is a common condition that has a substantial effect on the quality of life, an understanding of its treatment modalities is essential. Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies focus on PIH. This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Read more

This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Adele Shenoy BA, Raman Madan MD

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin, secondary to inflammatory skin conditions such as acne, atopic dermatitis, contact dermatitis, and psoriasis, as well as external factors such as burns and radiation therapy. An understanding of treatment strategies for PIH is essential, as it has a large impact on the quality of life.

Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies specifically address PIH. Thus, we conducted a literature review on PubMed using key words “post-inflammatory hyperpigmentation” OR “postinflammatory hyperpigmentation.”

Studies that did not specifically address PIH and articles that were not published in English were excluded. Additional studies were obtained by scanning references. This review adds to the current literature by discussing the evidence for topical therapies, chemical peels, and laser therapy used specifically for hyperpigmentation from PIH.

Read Full Article Now
Article Cited in this Post

Inclusive Derm Atlas PIH Images

You May Also Like

Journal of Drugs in Dermatology JDD Article about Amelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy

Amelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy

| Case Reports, Featured Articles, Latest News | No Comments
Case report: six weeks of gentian violet and trichloroacetic acid peel produced marked healing in dominant dystrophic epidermolysis bullosa with minimal discomfort The February 2026 JDD issue features a case…
Journal of Drugs in Dermatology JDD Article about Combined Use of Relabotulinum Toxin A and NASHA Gel Skinbooster for Rejuvenation of the Upper Third of the Face

Combined Use of Relabotulinum Toxin A and NASHA Gel Skinbooster for Rejuvenation of the Upper Third of the Face

| Aesthetics, Featured Articles, Latest News | No Comments
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months A preliminary clinical series tested…
Journal of Drugs in Dermatology JDD Article about Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges

Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges

| Aesthetics, Featured Articles, Latest News | No Comments
From the Vault: Review of the last decade finds biological rationale for skin and hair benefits, yet no FDA approvals and major gaps in standardization and clinical data Dive into…

Leave a Reply